GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » PhenixFIN Corp (NAS:PFX) » Definitions » EPS (Diluted)

PFX (PhenixFIN) EPS (Diluted) : $9.63 (TTM As of Jun. 2024)


View and export this data going back to 2011. Start your Free Trial

What is PhenixFIN EPS (Diluted)?

PhenixFIN's Earnings per Share (Diluted) for the three months ended in Jun. 2024 was $1.29. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was $9.63.

PhenixFIN's EPS (Basic) for the three months ended in Jun. 2024 was $1.29. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2024 was $9.63.

PhenixFIN's EPS without NRI for the three months ended in Jun. 2024 was $1.29. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2024 was $9.63.

During the past 12 months, PhenixFIN's average EPS without NRIGrowth Rate was 31.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, PhenixFIN's highest 3-Year average EPS without NRI Growth Rate was 58.00% per year. The lowest was -98.60% per year. And the median was -52.50% per year.


PhenixFIN EPS (Diluted) Historical Data

The historical data trend for PhenixFIN's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PhenixFIN EPS (Diluted) Chart

PhenixFIN Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -35.46 -24.16 0.48 -2.63 12.87

PhenixFIN Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.26 3.53 2.19 2.62 1.29

Competitive Comparison of PhenixFIN's EPS (Diluted)

For the Asset Management subindustry, PhenixFIN's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PhenixFIN's PE Ratio Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, PhenixFIN's PE Ratio distribution charts can be found below:

* The bar in red indicates where PhenixFIN's PE Ratio falls into.



PhenixFIN EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

PhenixFIN's Diluted EPS for the fiscal year that ended in Sep. 2023 is calculated as

Diluted EPS (A: Sep. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(26.918-0)/2.092
=12.87

PhenixFIN's Diluted EPS for the quarter that ended in Jun. 2024 is calculated as

Diluted EPS (Q: Jun. 2024 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(2.609-0)/2.020
=1.29

EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $9.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PhenixFIN  (NAS:PFX) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


PhenixFIN EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of PhenixFIN's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


PhenixFIN Business Description

Traded in Other Exchanges
N/A
Address
445 Park Avenue, 10th Floor, New York, NY, USA, 10022
PhenixFIN Corp formerly Medley Capital Corp is a non-diversified closed end management investment company operating in United States. Its investment objective is to generate current income and capital appreciation by lending directly to privately held middle market companies to expand their business, refinance and make acquisitions. It mainly invests in senior secured first lien term loans, senior secured second lien term loans, unitranche, senior secured first lien notes, subordinated notes and warrants and minority equity securities. It may also invest in securities of foreign companies. Portfolio of the company mainly consists of securities across all sectors. Revenue generated by the company comprises of interest income, dividend and other income earned through investments made.
Executives
David A Lorber director C/O FRONTFOUR CAPITAL GROUP LLC, 35 MASON STREET, 4TH FLOOR, GREENWICH CT 06830
Ellida Mcmillan officer: CFO & Chief Accounting Officer C/O ALCENTRA CAPITAL CORP., 200 PARK AVE, 7TH FL, NEW YORK NY 10166
Howard Amster director 23811 CHAGRIN BLVD # 200, BEACHWOOD OH 44122-5525
Arthur S Ainsberg director C/O ANGELO, GORDON & CO., L.P., 245 PARK AVENUE, 26TH FLOOR, NEW YORK NY 10167
Karin Hirtler-garvey director 112 W. 34TH STREET, NEW YORK NY 10120
Lowell W Robinson director 470 WEST END AVENUE, NEW YORK NY 10024
Fortress Investment Group Llc 10 percent owner 1345 AVENUE OF THE AMERICAS, 46TH FLOOR, NEW YORK NY 10105
Drawbridge Special Opportunities Fund Lp 10 percent owner C/O FORTRESS INVESTMENT GROUP LLC, 1345 AVENUE OF THE AMERICAS, 46TH FLOOR, NEW YORK NY 10105
Fig Llc 10 percent owner 1345 AVENUE OF THE AMERICAS, 46 FLOOR, NEW YORK NY 10105
Fortress Operating Entity I Lp 10 percent owner 1345 AVENUE OF THE AMERICAS, NEW YORK NY 10105
Fig Corp. 10 percent owner 1345 AVENUE OF THE AMERICAS, NEW YORK NY 10105
Db Med Investor I Llc 10 percent owner 1345 AVENUE OF THE AMERICAS, NEW YORK NY 10105
Drawbridge Special Opportunities Gp Llc 10 percent owner 1345 AVENUE OF THE AMERICAS, NEW YORK NY 10105
Drawbridge Special Opportunites Fund Ltd 10 percent owner 1345 AVENUE OF THE AMERICAS, NEW YORK NY 10105
Fortress Principal Investment Holdings Iv Llc 10 percent owner 1345 AVENUE OF THE AMERICAS, NEW YORK NY 10105